Healthcare Market Research Reports

Healthcare Market Research

With the growing competitive work environment and the pressures of the urban lifestyle, there has been an increasing demand for better healthcare services across the globe. More emphasis has been laid on the improvement in the healthcare sector and products pertaining to the segment.
The healthcare market research aims at providing a complete account of the aforementioned segment. The health-care industry incorporates several sectors that are dedicated to providing health care services and products. The health-care industry includes health care equipment and services as well as pharmaceuticals, biotechnology and life sciences. Various healthcare services that are growing in importance are, biotechnology, diagnostic substances, drug delivery, drug manufacturers, hospitals, medical equipment and instruments, diagnostic laboratories, nursing homes, providers of health care plans and home health care.
The reports listed under this category attempt to provide you with a reflection of the prevalent healthcare products and services in the market by means of the extensive range of market data, information and analysis. Our industry research reports give you a detailed insight of market conditions and forecasts, in addition to product trends and analysis. Industry overviews, market share and growth, sales statistics and projections, and healthcare company profiles are also featured.

The healthcare market research makes a careful study of all the past reports and makes estimates based on them. Further it studies the global outlook in the healthcare sector, while also profiling the competitors. Competitor analysis aids the business firms to strategize and execute their operations in the respective market.

ReportsnReports has business forecasts for your business, and offers you a comprehensive category-specific market outlook.

TITLE	Actions
2016-2020 Emerging Nucleic Acid Diagnostic Technologies and Strategic Profiles of Leading Suppliers Published in Mar 2016 \| US $ 3850 Onwards \| By Venture Planning Group This 180-page report provides detailed analyses of current and emerging nucleic acid testing technologies, and their potential market applications, including DNA sequencing, RNA probes, detection technologies, biochips, genosensor...
2016-2020 Emerging Transfusion Diagnostic Technologies and Strategic Profiles of Leading Suppliers Published in Mar 2016 \| US $ 3850 Onwards \| By Venture Planning Group This 114-page report provides assessments of such technologies as molecular diagnostics, monoclonal and polyclonal antibodies, immunoassays, microtitration plates, IT, lasers, synthetic red cell substitutes, genetically engineered...
2016-2020 Emerging Tumor Marker Testing Technologies and Strategic Profiles of Leading Suppliers Published in Mar 2016 \| US $ 3850 Onwards \| By Venture Planning Group This 185-page report provides detailed assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential application...
2016-2020 Global Cancer Diagnostics Market: Profiles of Leading Suppliers Published in Mar 2016 \| US $ 2500 Onwards \| By Venture Planning Group This report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R...
2016-2020 EU5 Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals, Public Health Labs--Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures, Innovative Technologies, Instrumentation Review Published in Mar 2016 \| US $ 6900 Onwards \| By Venture Planning Group The report presents a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report pr...
2016-2020 EU5 Immunoprotein Testing Market: Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts Published in Mar 2016 \| US $ 6500 Onwards \| By Venture Planning Group This new 273-page report from VPGMarketResearch provides analysis of the European immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of lea...
2016-2020 EU5 Endocrine Function Testing Market: France, Germany, Italy, Spain, UK--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts Published in Mar 2016 \| US $ 6500 Onwards \| By Venture Planning Group This new 310-page report from VPGMarketResearch provides a comprehensive analysis of the European endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strat...
2016-2020 EU5 Drugs of Abuse Testing Market: France, Germany, Italy, Spain, UK--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts Published in Mar 2016 \| US $ 6500 Onwards \| By Venture Planning Group This new 300-page report from VPGMarketResearch provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic pr...
2016-2020 EU5 Pap Smear/HPV Market: Competitive Strategies, Country Volume and Sales Segment Forecasts Published in Mar 2016 \| US $ 2850 Onwards \| By Venture Planning Group This report presents a detailed analysis of the Pap Smear/HPV testing market in Europe (France, Germany, Italy, Spain, UK), including clinical significance and current laboratory practice; as well as five-year test volume and sales f...
2016-2020 EU5 Cell Surface Marker Testing Market: France, Germany, Italy, Spain, UK--Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities Published in Mar 2016 \| US $ 3850 Onwards \| By Venture Planning Group The report provides an overview of the cell surface marker testing in Europe (France, Germany, Italy, Spain, UK), including 5-year forecasts for CD4, CD8, CD34 and other markers by country.RationaleThe use of ...
2016-2020 Emerging EU5 Sexually-Transmitted Disease Testing Market: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis--Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts Published in Mar 2016 \| US $ 7900 Onwards \| By Venture Planning Group This new 318-page report from VPGMarketResearch provides analysis of the European sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and st...
2016-2020 Emerging EU5 Respiratory Disease Testing Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts Published in Mar 2016 \| US $ 8300 Onwards \| By Venture Planning Group This new 335-page report from VPGMarketResearch provides analysis of the European respiratory disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic p...
2016-2020 Emerging EU5 Cell Surface Marker Testing Market: Hospitals, Commercial Labs, Ambulatory Care Centers---Competitive Strategies, Country Volume and Sales Segment Forecasts Published in Mar 2016 \| US $ 3850 Onwards \| By Venture Planning Group The report provides an overview of the cell surface marker testing in Europe (France, Germany, Italy, Spain, UK), including 5-year forecasts for CD4, CD8, CD34 and other markers by country.RationaleThe use of ...
2016-2020 Emerging Opportunities in the EU5 Sexually-Transmitted Diseases (STD) Diagnostic Testing Market Published in Mar 2016 \| US $ 7900 Onwards \| By Venture Planning Group This new 318-page report from VPGMarketResearch provides analysis of the European sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and st...
2016-2020 Emerging Opportunities in the EU5 Respiratory Diseases Diagnostic Testing Market Published in Mar 2016 \| US $ 8300 Onwards \| By Venture Planning Group This new 335-page report from VPGMarketResearch provides analysis of the European respiratory disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic p...
2016-2020 Emerging Opportunities in the EU5 Enteric Diseases Diagnostic Testing Market Published in Mar 2016 \| US $ 9400 Onwards \| By Venture Planning Group This new 363-page report from VPGMarketResearch provides analysis of the European enteric disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profi...
2016-2020 Emerging Opportunities in the EU5 HIV/AIDS Diagnostic Testing Market Published in Mar 2016 \| US $ 3950 Onwards \| By Venture Planning Group SummaryThis 5-country report presents detailed analyses of the AIDS diagnostics market in Europe (France, Germany, Italy, Spain, UK). For each country, the report provides test volume and sales forecasts for HIV/HIV-1/2/...
2016-2020 Emerging Opportunities in the EU5 Hepatitis Diagnostic Testing Market Published in Mar 2016 \| US $ 6900 Onwards \| By Venture Planning Group The report presents a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report pr...
2016-2020 POC/Point-of-Care Diagnostic Testing Markets: Ambulatory Care, Birth Centers, Cancer Clinics, ERs, Home Testing, ICUs, Nursing Homes, ORs, Physician Offices, Surgery Centers--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts for 300 Tests Published in Mar 2016 \| US $ 27500 Onwards \| By Venture Planning Group This new 1,230-page report from VPGMarketResearch contains 343 tables, and provides a comprehensive analysis of the 10 major POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, ...
2016-2020 World HIV/AIDS Diagnostic Testing Market: Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts Published in Mar 2016 \| US $ 5450 Onwards \| By Venture Planning Group The report presents a detailed analysis of the AIDS diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etiology of AIDS and other retrovir...

We are on:

Need Help?

Name *

Email *

Phone *

Country *

Subject *

Comments *

TITLE	Actions
2016-2020 Emerging Nucleic Acid Diagnostic Technologies and Strategic Profiles of Leading Suppliers Published in Mar 2016 \| US $ 3850 Onwards \| By Venture Planning Group This 180-page report provides detailed analyses of current and emerging nucleic acid testing technologies, and their potential market applications, including DNA sequencing, RNA probes, detection technologies, biochips, genosensor...
2016-2020 Emerging Transfusion Diagnostic Technologies and Strategic Profiles of Leading Suppliers Published in Mar 2016 \| US $ 3850 Onwards \| By Venture Planning Group This 114-page report provides assessments of such technologies as molecular diagnostics, monoclonal and polyclonal antibodies, immunoassays, microtitration plates, IT, lasers, synthetic red cell substitutes, genetically engineered...
2016-2020 Emerging Tumor Marker Testing Technologies and Strategic Profiles of Leading Suppliers Published in Mar 2016 \| US $ 3850 Onwards \| By Venture Planning Group This 185-page report provides detailed assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential application...
2016-2020 Global Cancer Diagnostics Market: Profiles of Leading Suppliers Published in Mar 2016 \| US $ 2500 Onwards \| By Venture Planning Group This report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R...
2016-2020 EU5 Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals, Public Health Labs--Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures, Innovative Technologies, Instrumentation Review Published in Mar 2016 \| US $ 6900 Onwards \| By Venture Planning Group The report presents a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report pr...
2016-2020 EU5 Immunoprotein Testing Market: Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts Published in Mar 2016 \| US $ 6500 Onwards \| By Venture Planning Group This new 273-page report from VPGMarketResearch provides analysis of the European immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of lea...
2016-2020 EU5 Endocrine Function Testing Market: France, Germany, Italy, Spain, UK--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts Published in Mar 2016 \| US $ 6500 Onwards \| By Venture Planning Group This new 310-page report from VPGMarketResearch provides a comprehensive analysis of the European endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strat...
2016-2020 EU5 Drugs of Abuse Testing Market: France, Germany, Italy, Spain, UK--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts Published in Mar 2016 \| US $ 6500 Onwards \| By Venture Planning Group This new 300-page report from VPGMarketResearch provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic pr...
2016-2020 EU5 Pap Smear/HPV Market: Competitive Strategies, Country Volume and Sales Segment Forecasts Published in Mar 2016 \| US $ 2850 Onwards \| By Venture Planning Group This report presents a detailed analysis of the Pap Smear/HPV testing market in Europe (France, Germany, Italy, Spain, UK), including clinical significance and current laboratory practice; as well as five-year test volume and sales f...
2016-2020 EU5 Cell Surface Marker Testing Market: France, Germany, Italy, Spain, UK--Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities Published in Mar 2016 \| US $ 3850 Onwards \| By Venture Planning Group The report provides an overview of the cell surface marker testing in Europe (France, Germany, Italy, Spain, UK), including 5-year forecasts for CD4, CD8, CD34 and other markers by country.RationaleThe use of ...
2016-2020 Emerging EU5 Sexually-Transmitted Disease Testing Market: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis--Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts Published in Mar 2016 \| US $ 7900 Onwards \| By Venture Planning Group This new 318-page report from VPGMarketResearch provides analysis of the European sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and st...
2016-2020 Emerging EU5 Respiratory Disease Testing Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts Published in Mar 2016 \| US $ 8300 Onwards \| By Venture Planning Group This new 335-page report from VPGMarketResearch provides analysis of the European respiratory disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic p...
2016-2020 Emerging EU5 Cell Surface Marker Testing Market: Hospitals, Commercial Labs, Ambulatory Care Centers---Competitive Strategies, Country Volume and Sales Segment Forecasts Published in Mar 2016 \| US $ 3850 Onwards \| By Venture Planning Group The report provides an overview of the cell surface marker testing in Europe (France, Germany, Italy, Spain, UK), including 5-year forecasts for CD4, CD8, CD34 and other markers by country.RationaleThe use of ...
2016-2020 Emerging Opportunities in the EU5 Sexually-Transmitted Diseases (STD) Diagnostic Testing Market Published in Mar 2016 \| US $ 7900 Onwards \| By Venture Planning Group This new 318-page report from VPGMarketResearch provides analysis of the European sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and st...
2016-2020 Emerging Opportunities in the EU5 Respiratory Diseases Diagnostic Testing Market Published in Mar 2016 \| US $ 8300 Onwards \| By Venture Planning Group This new 335-page report from VPGMarketResearch provides analysis of the European respiratory disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic p...
2016-2020 Emerging Opportunities in the EU5 Enteric Diseases Diagnostic Testing Market Published in Mar 2016 \| US $ 9400 Onwards \| By Venture Planning Group This new 363-page report from VPGMarketResearch provides analysis of the European enteric disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profi...
2016-2020 Emerging Opportunities in the EU5 HIV/AIDS Diagnostic Testing Market Published in Mar 2016 \| US $ 3950 Onwards \| By Venture Planning Group SummaryThis 5-country report presents detailed analyses of the AIDS diagnostics market in Europe (France, Germany, Italy, Spain, UK). For each country, the report provides test volume and sales forecasts for HIV/HIV-1/2/...
2016-2020 Emerging Opportunities in the EU5 Hepatitis Diagnostic Testing Market Published in Mar 2016 \| US $ 6900 Onwards \| By Venture Planning Group The report presents a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report pr...
2016-2020 POC/Point-of-Care Diagnostic Testing Markets: Ambulatory Care, Birth Centers, Cancer Clinics, ERs, Home Testing, ICUs, Nursing Homes, ORs, Physician Offices, Surgery Centers--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts for 300 Tests Published in Mar 2016 \| US $ 27500 Onwards \| By Venture Planning Group This new 1,230-page report from VPGMarketResearch contains 343 tables, and provides a comprehensive analysis of the 10 major POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, ...
2016-2020 World HIV/AIDS Diagnostic Testing Market: Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts Published in Mar 2016 \| US $ 5450 Onwards \| By Venture Planning Group The report presents a detailed analysis of the AIDS diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etiology of AIDS and other retrovir...